A Comparative Study of Newly Developed HPLC-DAD and UHPLC-UV Assays for the Determination of Posaconazole in Bulk Powder and Suspension Dosage Form

Table 2

Analysis of posaconazole in its pharmaceutical preparation (Noxafil 40 mg/mL suspension) using the proposed HPLC-DAD and UHPLC-UV methods.

Parameter	HPLC-DAD	UHPLC-UV
% Recovery ± SD^a	101.58 ± 1.87	103.03 ± 1.50
CV%	1.84	1.46
	1.21
	1.56

Mean ± standard deviation for four determinations.
Theoretical values for and at are 2.45 and 9.28, respectively.